Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP924505.RAChBuSg6UcuWVSSc5mh-X7gmpRXxE9vYdZKWroyRtfwA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP924505.RAChBuSg6UcuWVSSc5mh-X7gmpRXxE9vYdZKWroyRtfwA130_assertion type Assertion NP924505.RAChBuSg6UcuWVSSc5mh-X7gmpRXxE9vYdZKWroyRtfwA130_head.
- NP924505.RAChBuSg6UcuWVSSc5mh-X7gmpRXxE9vYdZKWroyRtfwA130_assertion description "[Combined molecular targeted antibody drug therapy for EGFR and HER-2 may be useful in the treatment of HNSCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924505.RAChBuSg6UcuWVSSc5mh-X7gmpRXxE9vYdZKWroyRtfwA130_provenance.
- NP924505.RAChBuSg6UcuWVSSc5mh-X7gmpRXxE9vYdZKWroyRtfwA130_assertion evidence source_evidence_literature NP924505.RAChBuSg6UcuWVSSc5mh-X7gmpRXxE9vYdZKWroyRtfwA130_provenance.
- NP924505.RAChBuSg6UcuWVSSc5mh-X7gmpRXxE9vYdZKWroyRtfwA130_assertion SIO_000772 22344385 NP924505.RAChBuSg6UcuWVSSc5mh-X7gmpRXxE9vYdZKWroyRtfwA130_provenance.
- NP924505.RAChBuSg6UcuWVSSc5mh-X7gmpRXxE9vYdZKWroyRtfwA130_assertion wasDerivedFrom befree-20140225 NP924505.RAChBuSg6UcuWVSSc5mh-X7gmpRXxE9vYdZKWroyRtfwA130_provenance.
- NP924505.RAChBuSg6UcuWVSSc5mh-X7gmpRXxE9vYdZKWroyRtfwA130_assertion wasGeneratedBy ECO_0000203 NP924505.RAChBuSg6UcuWVSSc5mh-X7gmpRXxE9vYdZKWroyRtfwA130_provenance.